References
- Apasani K (2007). RNA interference technology-from basic science to drug development. 125-35.
- Augello C, Caruso L, Maggioni M, et al (2009). Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer, 9, 125. https://doi.org/10.1186/1471-2407-9-125
- Brummelkamp TR, Bernards R, Agami R (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550-3. https://doi.org/10.1126/science.1068999
- Carrasco RA, Stamm NB, Marcusson E, et al (2011). Antisense inhibition of survivin expression as a cancer therapeutic. Mol Cancer Ther, 10, 221-32. https://doi.org/10.1158/1535-7163.MCT-10-0756
- Crnkovic-Mertens I, Hoppe-Seyler F, Butz K (2003). Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene, 22, 8330-6. https://doi.org/10.1038/sj.onc.1206973
- Chang H, Li S, Su Z (2008). Expression of Livin, Survivin, and IGF-2 in hepatocellular carcinoma tissue and its clinical implications. Shandong Med, 48, 1-3.
- Hung CS, Liu HH, Huang MT, et al (2012). Knockdown survivin expression reduces the efficacy of curcumin treatment in hepatocellular carcinoma cells. Ann Surg Oncol, 19, 3547-55 https://doi.org/10.1245/s10434-012-2393-4
- Kenneth NS, Duckett CS (2012). IAP proteins: regulators of cell migration and development. Curr Opin Cell Biol, 24, 871-5. https://doi.org/10.1016/j.ceb.2012.11.004
- Lau R, Pratt MA (2012). The opposing roles of cellular inhibitor of apoptosis proteins in cancer. ISRN Oncol, 2012, 928120.
- Liu H, Wang S, Sun H, et al (2010). Inhibition of tumorigenesis and invasion of hepatocellular carcinoma by siRNAmediated silencing of the livin gene. Mol Med Rep, 3, 903-7.
- Liu X, Wang A, Gao H, et al (2012). Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma. Int J Oncol, 41, 1021-8. https://doi.org/10.3892/ijo.2012.1540
- Oh BY, Lee RA, Kim KH (2011). siRNA targeting Livin decreases tumor in a xenograft model for colon cancer. World J Gastroenterol, 17, 2563-71. https://doi.org/10.3748/wjg.v17.i20.2563
- Portt L, Norman G, Clapp C, et al (2011). Anti-apoptosis and cell survival: a review. Biochim Biophys Acta, 1813, 238-59. https://doi.org/10.1016/j.bbamcr.2010.10.010
- Sibley CR, Seow Y, Wood MJ (2010). Novel RNA-based strategies for therapeutic gene silencing. Mol Ther, 18, 466-76. https://doi.org/10.1038/mt.2009.306
- Song J, Cao L, Li Y (2013). RNA interferencemediated inhibition of survivin and VEGF in pancreatic cancer cells in vitro. Mol Med Rep, 7, 1651-5. https://doi.org/10.3892/mmr.2013.1361
- Song J, Giang A, Lu Y, et al (2008). Multiple shRNA expressing vector enhances efficiency of gene silencing. BMB Rep, 41, 358-62. https://doi.org/10.5483/BMBRep.2008.41.5.358
- Wang R, Lin F, Wang X, et al (2008). Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells. Cancer Gene Ther, 15, 402-12. https://doi.org/10.1038/cgt.2008.16
- Xing J, Jia CR, Wang Y, et al (2012). Effect of shRNA targeting survivin on ovarian cancer. J Cancer Res Clin Oncol, 138, 1221-9. https://doi.org/10.1007/s00432-012-1196-0
- Yang D, Song X, Zhang J, et al (2010). Therapeutic potential of siRNA-mediated combined knockdown of the IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24 cells. Acta Biochim Biophys Sin (Shanghai), 42, 137-44. https://doi.org/10.1093/abbs/gmp118
Cited by
- A novel inducible lentiviral system for multi-gene expression with human HSP70 promoter and tetracycline-induced promoter vol.101, pp.9, 2017, https://doi.org/10.1007/s00253-017-8132-9
- Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non-small cell lung cancer cells vol.16, pp.5, 2017, https://doi.org/10.3892/mmr.2017.7490